Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: Macro science. Palette: D, bold color field. Extreme close-up microscopy-style image of a dense cluster of oval, rod-shaped bacteria with a slightly mucous, glossy membrane texture, shot from a shallow top-down angle with a razor-thin focal plane. Most of the colony sits in the sharp center, softening into creamy blur at the edges. The cells are warm ivory with subtle translucent depth, resting on a saturated tomato-red backdrop. A scattering of sparser, isolated cells on one side suggests "low baseline" and hints at the subgroup story. One or two cells carry a faint electric green (#00e676) fluorescent rim glow. Lighting is soft, directional studio light with gentle specular highlights on the cell walls and clean shadows in warm red tones. Mood: curious, precise, quietly skeptical, with a vivid but grounded look. No text and no blue cast.
Supplements

Akkermansia Gagal Nggawe Tujuan Utama—Nanging Ana ing Wong sing Kekurangan

Nova Chen · · 4 min read
#clinical trial #insulin sensitivity #akkermansia #gut microbiome #probiotics #glp 1 #metabolic syndrome

Akkermansia Gagal Nggawe Tujuan Utama—Nanging Ana ing Wong sing Kekurangan

Bakteri usus sing dipasteurisasi lan asring dipromosikaké minangka “penambah GLP‑1 alami” iki baru‑baru iki ngalami uji coba double‑blind paling gedhé ing manungsa. Ing tujuan pokok, bakteri iki ora kasil. Nanging yèn didelok luwih jero sapa sing njupuk, katon manawa mikroba iki bisa migunani kanggo wong sing wiwitane kekurangan bakteri iki ing ususe.

Ringkesan: Gagal Nggawe Tujuan Utama

Uji coba iki, diterbitaké ing Gut Microbes (2026) déning Suenaert, Cani, de Vos lan kanca‑kancané, nyoba strain Akkermansia muciniphila MucT sing wis dipasteurisasi. Para peserta ngunjuk kapsul sing ngandhut 30 milyar sel saben dina, suwéné patang sasi.

Desainé kuwat: double‑blind, placebo‑controlled, lan multicentre (Irlandia lan Jerman), kalebu 142 wong diwasa sing nduwèni sindrom metabolik, apa ana utawa ora prediabetes. Uji iki kacathet minangka NCT05114018.

Tujuan utama yaiku ngukur sensitivitas insulin sak awak nganggo indeks Matsuda. Ing populasi intention‑to‑treat, ora ana bedané karo placebo. Iki asil pusat saka studi iki, lan sakabèhé sing kapacak mengko mung ngelanjutin asil iki.

Napa Kabeh Wong Isih Ngrembug Bab Iki

Sawisé asil utama, para peneliti nindakake analisis eksploratori. Eksploratori tegesé uji coba ora dirancang kanggo mbuktekaké temuan iku, mula kudu diperlakuaké minangka petunjuk. Ing telung sasi panggunaan, padha nglaporaké:

  • Peserta prediabetes: kira‑kira 12 % luwih apik ing sensitivitas insulin hepatic adhedhasar HOMA (p = 0,05).
  • Peserta umur 63 taun utawa luwih: perbaikan sing padha ing sensitivitas insulin hepatic (p = 0,05).
  • GLP‑1: kenaikan sing luwih gedhé sawisé OGTT dibandhingake karo placebo (p < 0,01).

GLP‑1 iku hormon sing ditiru déning obat agonis reseptor GLP‑1. Kenaikan respon GLP‑1 alami sawisé glukosa menarik, nanging ora padha karo efek obat. Tulisan iki ora nuduhaké penurunan bobot awak utawa kontrol glukosa sing sarupa karo obat‑obatan kasebut.

Kejutan: Kasil Muncul Ing Wong sing Kekurangan Bakteri Iki

Para peneliti uga nganalisis urutan mikrobioma usus peserta nganggo metagenomik jero. Intervensi iki mung ngowahi sethithik komposisi mikroba sakabèhé. Nanging mikrobioma awal peserta béda karo wong sehat sing padha umure, lan subkelompok sing ngandhut jumlah gén Akkermansia ing tingkat rendah metu minangka sorotan.

Ing subkelompok iki, sawisé telung sasi, perlakuan ngungguli placebo ing:

  • Sensitivitas insulin (indeks Matsuda lan HOMA‑S) (p < 0,05)
  • Kenaikan GLP‑1 sawisé OGTT (p < 0,05)
  • Lemak trunk sing mudhun (p < 0,05)
  • Bobot awak sing mung nuduhaké trend (p = 0,06, ora signifikan sacara statistik)

Penulis nyatakaké yèn kelompok iki “bener‑bener butuh” intervensi. Logikane prasaja: nambahaké bakteri ing usus sing wis kebak ora bakal ngowahi apa‑apa, nanging nambahaké ing panggonan sing kurang bisa menehi pangaruh luwih gedhé. Nanging iki hipotesis sing muncul sawisé uji coba, dudu tes sing wis dipre‑specify.

Pira Nilai Sing Kudune Diparingi Marang Iki?

Supaya ora nglokro, ayo dipikiraké kanthi kritis.

  • Tujuan utama gagal. Secara keseluruhan, uji coba negatif kanggo pitakonan paling penting.
  • Subkelompok post‑hoc. Temuan prediabetes, umur, lan Akkermansia rendah iku eksploratori. Nggabungake data dadi subkelompok nambah kemungkinan positif palsu, lan sawetara asil pas ing ambang p = 0,05.
  • Wektu evaluasi ora selaras. Tujuan utama dievaluasi ing patang sasi, nalika asil eksploratori sing diangkat ana ing telung sasi.
  • Ukuran subkelompok ora cetha. Ringkesan ora menehi angka peserta ing grup Akkermansia rendah, dadi akurasi asil iki ora jelas.
  • Keterlibatan industri. Sawetara penulis dadi pegawai utawa konsultan The Akkermansia Company. Loro (de Vos lan Cani) dadi co‑founder (Cani mantan), lan loro‑loro uga penemu paten sing gegayutan. Penulis liya kerja ing Clinical Microbiomics. Iki ora otomatis mbatalaké data, nanging replikasi independen dadi penting.
  • Populasi. Asil mung relevan kanggo wong diwasa sing kegemukan utawa obesitas karo sindrom metabolik, dudu kanggo masyarakat umum.

Studi iki ndhukung karya prapublikasi sadurungé lan studi proof‑of‑concept ing wong kegemukan lan prediabetes sing nuduhaké manfaat. Uji coba gedhé iki mendingake antusiasme awal lan ngetokaké kelompok responden sing potensial.

Saran Praktis

Dosis sing dienggo ing uji coba: 30 milyar sel saben dina saka A. muciniphila MucT sing dipasteurisasi, ing bentuk kapsul, kanggo 3–4 sasi. Ringkesan ora nyebut cara panggunaan (mbiyen mangan utawa wektu dina), mula ora ana saran timing sing adhedhasar bukti. Produk lan strain liyané ora dites, dadi ora bisa diasumsikaké asil padha.

Sapa sing dadi target: Wong diwasa sing kegemukan utawa obesitas lan nduwèni sindrom metabolik, utamané sing prediabetes utawa umur luwih tuwa, amarga sinyal eksploratori katon ing kelompok iki. Ide babagan “Akkermansia rendah” iku sing paling menarik, nanging ora ana tes standar utawa ambang sing ditemtokaké. Metagenomik stool dipigunakaké ing uji coba, lan ringkesan ora nyedhiyakake ambang praktis.

Sapa sing kudu ati‑ati utawa nyingkiri:

  • Sing ngarep‑arep ganti obat GLP‑1. Data ora ndhukung iki.
  • Sing ngarep‑arep manfaat kepastian. Analisis utama negatif.
  • Penderita diabetes sing lagi ngonsumsi obat, utawa sing immunokompromais utawa lara serius. Iki wacana umum, dudu temuan khusus. Konsultasi karo dokter sadurunge nambah suplemen bakteri.
  • Sing mikir bisa ngentekaké diet, olahraga, utawa perawatan resep.

Kesimpulan

Uji coba iki ora nuduhaké yèn Akkermansia sing dipasteurisasi nambah sensitivitas insulin ing populasi wong kanthi sindrom metabolik sacara umum. Sing ditawakake yaiku gagasan sing masuk akal lan bisa dites: manfaaté bisa gumantung marang sapa sing njupuk, lan wong sing nduwèni tingkat Akkermansia rendah mungkin entuk respon paling apik. Langkah sabanjuré yaiku uji coba sing milih peserta kanthi tingkat Akkermansia rendah saka wiwitan lan netepaké titik akhir sadurunge. Nganti wektu kuwi, anggep iki menjanjikan nanging durung kabukten.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: Macro science. Palette: D, bold color field. Extreme close-up microscopy-style photograph of a dense cluster of oval, rod-shaped bacterial cells, rendered as slightly wrinkled, matte, pale cream-white forms with visible surface texture. They rest on a smooth, saturated magenta-pink gel surface. Several cells in the foreground are crisp, while the rest fall into soft shallow depth of field. One cell near the center is split open and visibly hollow, to suggest a dead, heat-treated organism. Camera is a low three-quarter angle, as if through a scanning microscope. Lighting is a single hard, warm-white side light that casts short crisp shadows and creates bright rim highlights. A thin electric green (#00e676) line of reflected light traces the edge of one cell. The mood is stark, curious and quietly skeptical. There is no text and no labels.
metabolism

Bakteri Usus Sing Luwih Apik Nalika Mati: Kauntungan 29 % saka Akkermansia

BY HELIX WARD ·

Ing percobaan manungsa kaping pisan nganggokake *Akkermansia muciniphila* versi pasteurisasi (dipatèni panas), dudu sing urip, ditemokaké peningkatan sensitivitas insulin 28,62 % lan penurunan insulin puasa 34,08 % dibandhingake plasebo ing wong kegemukan lan tahan insulin. Perubahan bobot lan lemak ora ngancik tingkat signifikan sacara statistik, lan sawatara penulis nduwèni paten lan dadi co‑founder perusahaan sing ngedol bakteri iki. Artikel iki ngrembug asil studi, apa sing ora kasat mata, lan apa sing kudu dipriksa sadurunge tuku suplemen.
Approach 1, macro science, in palette D, bold color field. Extreme close-up microscopy-style photograph of a dense colony of rod-shaped, slightly branched Bifidobacterium cells, rendered as real textured organic forms with soft translucent walls and subtle surface detail. The cells are warm cream and ivory, clustered in the center and thinning toward the edges. The whole backdrop is a saturated tomato-red to orange field, smooth and out of focus, so the bacteria stand out in sharp contrast. A few scattered tiny crystalline metabolite specks glow faintly electric green (#00e676) near the colony. Camera angle is straight-on, slightly oblique, with a very shallow depth of field. Lighting is soft, diffuse backlight with gentle rim highlights on the cell edges and no harsh shadows. The mood is vivid, curious and hopeful, scientific but warm, with no blue cast anywhere. No text.
longevity

Mikroba Usus iki Ngasilake 5‑AVAB, Molekul sing Ngendhalekake Inflammaging

BY NOVA CHEN ·

Mikroba usus sing alon‑alon ilang nalika awakku nambah, bisa dadi pemain penting luwih saka sing dibayangaké. Panalitèn ing *Nature Aging* nemokaké *Bifidobacterium pseudocatenulatum* sing tapaké sithik ing wong tuwa saka macem‑macem kohort Tionghoa. Menehi tikus tuwa liwat tutuk, mikroba iki nyuda peradangan kronis (inflammaging) ing pirang‑pirang organ lan nambah healthspan. Efek kasebut dikaitaké karo metabolit 5‑AVAB sing uga mudhun karo umur. Kene sing wis kawujud, apa sing isih perlu dibuktekaké ing manungsa, lan kepiye maca kabar iki kanthi wicaksana.
A softly lit editorial still life on a pale oat-colored linen surface, shot from a slightly elevated three-quarter angle in a wide landscape frame. At center-left, a small matte white ceramic dish holds a modest pile of fine off-white powder, with a tiny brushed-brass measuring spoon resting beside it. Next to the dish stands a minimalist amber glass supplement bottle with a plain cream label and no readable text. A few capsules spill casually across the linen, some translucent and some opaque ivory. On the right side of the composition, a ripe blood orange cut in half and a handful of raw almonds sit on a light ash-wood board. A sprig of fresh rosemary adds a muted green accent. A sheer glass of water catches the light and throws a soft, rippled caustic pattern across the fabric. In the background, out of focus, a woman's hand in a soft sage-green knit sleeve rests near a ceramic mug. This suggests a calm morning routine without showing a face. Behind her, a tall window casts diffused, golden-hour light from the upper left, with gentle shadows and a creamy, shallow depth of field. The palette is warm and restrained: oat, ivory, terracotta, sage, and amber, with a single pop of coral from the blood orange. A thin, abstract line of muted terracotta paint, like a brushed arc, sweeps across the upper right background. It subtly evokes a rising curve without becoming a literal chart. The mood is calm, trustworthy, and contemporary, like a premium wellness and science journal feature. The image has crisp focus on the powder and bottle, natural film-like grain, soft contrast, and generous negative space in the upper third for headline overlay. It looks like a high-end editorial photograph with no text, logos, or futuristic elements.
metabolism

Panemuan Kapisan Manungsa NMN: 250 mg Saben Dina Nambah Sensitivitas Insulin Otot Kira‑kira 25 % ing Wanita Prediabetes

BY DR. SYNAPSE ·

NMN wis suwe dadi idola ing pasar anti‑penuaan, nanging bukti saka manungsa durung kuwat nganti ana uji coba Washington University ing 2021 sing diterbitake ing *Science*. Ing wanita menopause sing kena prediabetes lan kegemukan utawa obesitas, 250 mg NMN saben dina sajrone 10 minggu nambah sensitivitas insulin otot kira‑kira 25 %. Sinyal insulin ing otot lan gén sing kagandheng karo remodeling otot uga membaik, déné kelompok plasebo ora ana owah‑owahan. Nanging keuntungan iki winates, lan studi ora nuduhaké NMN mudhunaké glukosa darah utawa mbalèkaké prediabetes. Ing ngisor iki gambaran apa sing ditemokaké, sapa sing bisa entuk manfaat, lan apa sing ora diganti.
Approach: conceptual metaphor, with a natural palette. A single walnut is cracked open on a rough wooden board, and its two halves sit slightly apart. The halves are shot in tight macro from a low three-quarter angle. The walnut's brain-like folds are the focus. Between the halves, a thin cluster of fine, dark brown tannin-stained fibers stretches like a bridge. Beside it sits a small pile of shell fragments with a few strands of green walnut husk. A small, sharp, electric green (#00e676) leaf catches the light at the edge of the frame. The background is a softly blurred window-lit kitchen garden in leafy greens and warm earth tones. Soft natural daylight comes from the left and gives gentle shadows and visible texture on the nut's ridges. The mood is calm, curious and quietly scientific, with a fresh morning feel and no blue cast.
longevity

Urolithin A: Produk Samping Usus Kenari sing Nggandhengake Ketebalan Otak

BY NOVA CHEN ·

Mangan kenari, bakteri ing ususmu bakal ngowahi ellagitannin dadi urolithin, senyawa sing mungkin ana gandhengé karo cara otakmu menua. Ing sub‑studi MRI suwéné 2 taun saka percobaan WAHA, kenaikan urolithin A, urolithin C, lan urolithin C‑glukuronida disambungaké karo tetepé ketebalan korteks otak, utamané ing belahan tengen. Pola iki luwih cetha ing wong sing nduwèni metabotype B. Nanging iki mung asosiasi ing trial acak, dudu bukti sebab‑akibat, lan ora ngandharaké apa‑apa babagan suplemen urolithin A.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文